(TBI) TrueBlue - Ratings and Ratios
Staffing, Recruitment, Outsourcing, Contingent, Workforce
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 128% |
| Value at Risk 5%th | 119% |
| Relative Tail Risk | -43.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.59 |
| Alpha | -57.45 |
| CAGR/Max DD | -0.48 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.498 |
| Beta | 0.941 |
| Beta Downside | 1.250 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.46% |
| Mean DD | 48.17% |
| Median DD | 49.61% |
Description: TBI TrueBlue January 01, 2026
TrueBlue, Inc. (NYSE:TBI) delivers workforce solutions across the U.S., Canada, the U.K., Australia, and Puerto Rico through three operating segments: PeopleReady (contingent staffing for construction, transportation, manufacturing, retail, hospitality, and energy), PeopleManagement (on-site industrial staffing and commercial driver services for manufacturing, warehousing, distribution, and transportation), and PeopleScout (recruitment process outsourcing, talent advisory, and a technology platform called Affinix for permanent-worker sourcing). The firm, originally Labor Ready, was incorporated in 1985, rebranded in 2007, and is headquartered in Tacoma, Washington.
Key performance indicators from the most recent fiscal year (2023) show revenue of approximately $1.1 billion, representing a 4 % year-over-year increase, and an adjusted EBITDA margin near 6 %, reflecting modest profitability in a labor-intensive sector. The company’s backlog-primarily driven by multi-year contracts in construction and logistics-stood at roughly $250 million, indicating a steady pipeline of demand despite a competitive market.
Macro-level drivers that materially affect TrueBlue’s outlook include the persistent tightness in the U.S. labor market, which sustains premium pricing for contingent workers, and the ongoing rebound in construction spending, which is projected to grow at a 3-4 % annual rate through 2027. Conversely, rising wage inflation and potential regulatory changes around gig-economy labor could compress margins if not managed proactively.
For a deeper dive into TrueBlue’s valuation metrics and comparable peer analysis, the ValueRay platform offers a concise dashboard you may find useful.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-28.1m TTM) > 0 and > 6% of Revenue (6% = 95.0m TTM) |
| FCFTA -0.09 (>2.0%) and ΔFCFTA -4.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.95% (prev 7.81%; Δ 2.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.12 (>3.0%) and CFO -81.5m <= Net Income -28.1m (YES >=105%, WARN >=100%) |
| Net Debt (106.5m) to EBITDA (1.19m) ratio: 89.59 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.9m) change vs 12m ago 0.65% (target <= -2.0% for YES) |
| Gross Margin 24.02% (prev 25.82%; Δ -1.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 227.4% (prev 238.3%; Δ -10.87pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -6.41 (EBITDA TTM 1.19m / Interest Expense TTM 4.27m) >= 6 (WARN >= 3) |
Altman Z'' 3.60
| (A) 0.23 = (Total Current Assets 313.2m - Total Current Liabilities 155.7m) / Total Assets 690.5m |
| (B) 0.47 = Retained Earnings (Balance) 326.1m / Total Assets 690.5m |
| (C) -0.04 = EBIT TTM -27.4m / Avg Total Assets 696.5m |
| (D) 0.79 = Book Value of Equity 304.3m / Total Liabilities 386.2m |
| Total Rating: 3.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 14.44
| 1. Piotroski 0.50pt |
| 2. FCF Yield -26.93% |
| 3. FCF Margin -4.13% |
| 4. Debt/Equity 0.42 |
| 5. Debt/Ebitda 89.59 |
| 6. ROIC - WACC (= -10.24)% |
| 7. RoE -9.17% |
| 8. Rev. Trend -90.00% |
| 9. EPS Trend -73.07% |
What is the price of TBI shares?
Over the past week, the price has changed by -2.15%, over one month by -11.65%, over three months by -28.12% and over the past year by -41.96%.
Is TBI a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.5 | 86.8% |
| Analysts Target Price | 8.5 | 86.8% |
| ValueRay Target Price | 3 | -33.6% |
TBI Fundamental Data Overview January 01, 2026
P/E Forward = 56.1798
P/S = 0.086
P/B = 0.4624
P/EG = 4.0048
Beta = 1.46
Revenue TTM = 1.58b USD
EBIT TTM = -27.4m USD
EBITDA TTM = 1.19m USD
Long Term Debt = 68.2m USD (from longTermDebt, last quarter)
Short Term Debt = 11.1m USD (from shortTermDebt, last quarter)
Debt = 126.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 106.5m USD (from netDebt column, last quarter)
Enterprise Value = 242.7m USD (136.2m + Debt 126.4m - CCE 19.9m)
Interest Coverage Ratio = -6.41 (Ebit TTM -27.4m / Interest Expense TTM 4.27m)
FCF Yield = -26.93% (FCF TTM -65.4m / Enterprise Value 242.7m)
FCF Margin = -4.13% (FCF TTM -65.4m / Revenue TTM 1.58b)
Net Margin = -1.78% (Net Income TTM -28.1m / Revenue TTM 1.58b)
Gross Margin = 24.02% ((Revenue TTM 1.58b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 22.70% (prev 23.61%)
Tobins Q-Ratio = 0.35 (Enterprise Value 242.7m / Total Assets 690.5m)
Interest Expense / Debt = 0.84% (Interest Expense 1.06m / Debt 126.4m)
Taxrate = -59.00% (out of range, set to none) (711.0k / -1.21m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.01 (Total Current Assets 313.2m / Total Current Liabilities 155.7m)
Debt / Equity = 0.42 (Debt 126.4m / totalStockholderEquity, last quarter 304.3m)
Debt / EBITDA = 89.59 (Net Debt 106.5m / EBITDA 1.19m)
Debt / FCF = -1.63 (negative FCF - burning cash) (Net Debt 106.5m / FCF TTM -65.4m)
Total Stockholder Equity = 306.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.07% (Net Income -28.1m / Total Assets 690.5m)
RoE = -9.17% (Net Income TTM -28.1m / Total Stockholder Equity 306.8m)
RoCE = -7.31% (EBIT -27.4m / Capital Employed (Equity 306.8m + L.T.Debt 68.2m))
RoIC = -5.32% (negative operating profit) (EBIT -27.4m / (Assets 690.5m - Curr.Liab 155.7m - Cash 19.9m))
WACC = 4.92% (E(136.2m)/V(262.6m) * Re(9.48%) + (debt cost/tax rate unavailable))
Discount Rate = 9.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.92%
Fair Price DCF = unknown (Cash Flow -65.4m)
EPS Correlation: -73.07 | EPS CAGR: -17.57% | SUE: 0.35 | # QB: 0
Revenue Correlation: -90.00 | Revenue CAGR: -9.30% | SUE: 1.82 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.10 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.26 | Chg30d=-0.097 | Revisions Net=-1 | Growth EPS=+151.6% | Growth Revenue=+4.6%
Additional Sources for TBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle